Description:
PITT-HOPKINS SYNDROME; PTHS
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases PIGI Consented Sample |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
Italian, Scottish, French, English, Irish
|
Country of Origin
|
USA
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
TCF4 |
Chromosomal Location |
18q21.2 |
Allelic Variant 1 |
Frameshift; PITT-HOPKINS SYNDROME; PTHS |
Identified Mutation |
Arg262ProfsX3 (c.784-785insCA) |
Remarks |
Clinically affected; onset of symptoms at 6 months; diagnosed at 2.5 years; mild dysmorphic features: slightly triangular face and small chin; microcephaly; cortical visual impairment; amblyopia (left eye); exotropia; staring spells; hypotonia; limited walking ability; constipation; global developmental delay; happy disposition; developmental milestones: first rolled over at 5 months old (but lost ability at 6 months until 12 months), could sit with support by 12 months of age; able to pull stand at 2.5 years, but not walking independent of a PT walker; unable to feed herself at 2.5 years; started to babble at 7 months old, at 2.5 years, non-verbal and with basic receptive language abilities; brain MRI and EEG at 3 years were normal; heterozygous for a de novo novel variant in the TCF4 gene: c.784_785insCA (p.Arg262ProfsX3) (human genome build GRCh37/UCSC hg19); medications/supplements: magnesium hydroxide, ergocalciferol (Vit D2), lactobacillus combo no.11, omega-3s/dha/epa/fish oil, surgeries: bilateral lateral rectus recession, left medial rectus resection, tympanostomy tubes (bilateral); assistive devices: walker; glasses; therapies: occupational, physical, and speech; family history: male maternal cousin with intermittent exotropia and delayed walking-developmentally normal at 5 years of age; female first cousin-once removed with epilepsy diagnosed in her 20s-seizures controlled with medication. |
|
|